Ryan H. Saadi - 05 Jun 2024 Form 4 Insider Report for Tevogen Bio Holdings Inc. (TVGN)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Kirti Desai, Attorney-in-Fact
Issuer symbol: TVGN
Transactions as of: 05 Jun 2024
Net transactions value: +$2,000
Form type: 4
Filing time: 07 Jun 2024, 16:29:51 UTC
Previous filing: 16 Feb 2024
Next filing: 09 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVGN	Common Stock	Purchase	$2,000	+2,607	+0%	$0.7671	118,252,659	05 Jun 2024	Direct	F1
holding	TVGN	Common Stock						193,924	05 Jun 2024	By wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7635 to $0.7671, inclusive. The reporting person undertakes to provide to Tevogen Bio Holdings Inc., any security holder of Tevogen Bio Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

Content

The price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7635 to $0.7671, inclusive. The reporting person undertakes to provide to Tevogen Bio Holdings Inc., any security holder of Tevogen Bio Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.